Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |